合并多重疾病的类风湿关节炎患者对整体疾病活动度的评分差异
该研究基于纵向队列(n=1,040)比较合并多重疾病(RA-MM)与仅患RA患者的患者整体评估(PtGA)。RA-MM患者PtGA更高(更差),且随合并疾病数量增加呈线性趋势(P<0.01);匹配后RA-MM组PtGA均值30.5±24.3高于仅RA组25.6±22.9(ΔPtGA 4.9±26.7,P<0.01),差异主要由疲劳(18%)、疼痛(17%)和mHAQ评分(9%)解释。
要点
- 合并多重疾病的RA患者PtGA评分更高(更差),且随合并疾病数量增加呈线性趋势。
- 匹配后RA-MM组PtGA均值30.5±24.3,仅RA组25.6±22.9,ΔPtGA 4.9±26.7(P<0.01)。
- 疲劳(18%)、疼痛(17%)和mHAQ评分(9%)是ΔPtGA的独立贡献因素。
核心结论
- 合并多重疾病的RA患者PtGA评分更高(更差),多重疾病负担可能影响患者对RA疾病活动度的感知。
- PtGA差异主要由疲劳和疼痛的差异解释。
研究设计与样本
- 纵向队列研究,纳入1,040例RA患者,其中RA-MM患者575例。
- 对294例RA-MM患者与仅RA患者按肿胀关节数、压痛关节数、评估者整体评估和病程进行匹配,比较PtGA均值差异。
- 采用线性回归模型计算各患者特征对ΔPtGA解释变异的贡献(半偏R²),并以总R²的百分比表示。
主要发现
- RA-MM患者报告更高的PtGA,且PtGA随合并疾病数量增加而升高(线性趋势P<0.01),校正疾病活动度、年龄和病程后仍显著。
- 匹配后RA-MM组PtGA均值±SD为30.5±24.3,仅RA组为25.6±22.9,平均ΔPtGA为4.9±26.7(配对t检验P<0.01)。
- 对ΔPtGA有独特贡献的变量为疲劳(18%)、疼痛(17%)和改良健康评估问卷(mHAQ)评分(9%)。
关键数值与推荐
- PtGA采用0-100 mm量表。
- RA-MM患者PtGA均值±SD为30.5±24.3,仅RA患者为25.6±22.9,平均ΔPtGA为4.9±26.7,P<0.01。
- 疲劳、疼痛和mHAQ评分对ΔPtGA的贡献分别为18%、17%和9%。
临床怎么用
- 解读RA患者PtGA时需考虑合并多重疾病的影响,避免将合并疾病导致的疲劳和疼痛误判为RA疾病活动。
- 对合并多重疾病的RA患者,可结合疲劳、疼痛和mHAQ评分综合评估疾病活动度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To quantify differences and determine the factors contributing to the difference in patient global assessment of rheumatoid arthritis (RA) disease activity (PtGA) between RA patients with multiple morbidities (RA-MM) and those with RA only. METHODS: We compared the PtGA between RA-MM patients and those with RA only, followed up in a longitudinal cohort (n = 1,040). In analyses performed on RA-MM patients (n = 575) and those with RA only (matched for swollen joint count, tender joint count, evaluator global assessment, and disease duration), the mean difference in PtGA (ΔPtGA) between the 2 groups was assessed. The contribution of patient characteristics to the explained variation of ΔPtGA in the matched cohort was calculated as semipartial R2 and summarized as the percentage of the total R2 in linear regression models. RESULTS: RA-MM patients reported higher (or worse) PtGA, with an increased PtGA associated with more morbidities (P for linear trend < 0.01); this relationship remained significant after adjustment for disease activity, age, and disease duration. After matching 294 RA-MM patients to those with RA only, the pairwise comparison of mean PtGA (on a scale of 0-100 mm) was significantly higher (worse) for RA-MM patients (mean ± SD 30.5 ± 24.3) versus those with RA only (25.6 ± 22.9) (mean ΔPtGA 4.9 ± 26.7; P < 0.01 by paired t-test). Variables uniquely contributing to ΔPtGA were fatigue (18%), pain (17%), and modified Health Assessment Questionnaire scores (9%). CONCLUSION: In RA patients with multiple morbidities, the perception of RA disease activity as measured by the PtGA might be impacted by the burden of multiple diseases in one individual. RA-MM patients have higher (worse) levels of PtGA scores compared to patients with RA only. The difference in PtGA is mainly explained by differences in fatigue and pain.
引用
- Radner H, Yoshida K, Tedeschi S, et al. Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities. Arthritis Rheumatol. 2017. PMID: 27860467. doi:10.1002/art.39988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。